Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of August 2026

  1. Beam Therapeutics Inc.

    World Rank (Aug-2026)
    5,282
    Market Cap (Aug-2026)
    2.763 Billion USD
    World Rank (Jan-05-2024)
    5,482
    Market Cap (Jan-05-2024)
    2.121 Billion USD
    World Rank (Jul-30-2023)
    5,105
    Market Cap (Jul-30-2023)
    2.392 Billion USD
    World Rank (Dec-25-2022)
    4,254
    Market Cap (Dec-25-2022)
    2.844 Billion USD
    World Rank (Jan-07-2022)
    3,394
    Market Cap (Jan-07-2022)
    4.79 Billion USD
    Annual Revenue in USD
    140 Million USD
    Annual Operating Income in USD
    -384 Million USD
    Annual Net Income in USD
    -80 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Beam Therapeutics is a Biotechnology company developing precision genetic medicines through the use of base editing. The headquarters is in USA.

    Facts About Company

    The company annual revenue is 60 million USD and net loss was -289 million USD as on Dec-2022.

  2. Regencell Bioscience Holdings Ltd

    World Rank (Aug-2026)
    5,355
    Market Cap (Aug-2026)
    2.695 Billion USD
    World Rank (Jan-05-2024)
    19,846
    Market Cap (Jan-05-2024)
    0.137 Billion USD
    World Rank (Jul-30-2023)
    16,994
    Market Cap (Jul-30-2023)
    0.243 Billion USD
    World Rank (Dec-25-2022)
    14,236
    Market Cap (Dec-25-2022)
    0.380 Billion USD
    World Rank (Jan-07-2022)
    14,583
    Market Cap (Jan-07-2022)
    0.42 Billion USD
    Headquarters Country
  3. ATAI Life Sciences N.V.

    World Rank (Aug-2026)
    5,361
    Market Cap (Aug-2026)
    2.692 Billion USD
    World Rank (Jan-05-2024)
    16,036
    Market Cap (Jan-05-2024)
    0.286 Billion USD
    World Rank (Jul-30-2023)
    15,102
    Market Cap (Jul-30-2023)
    0.342 Billion USD
    World Rank (Dec-25-2022)
    13,197
    Market Cap (Dec-25-2022)
    0.443 Billion USD
    World Rank (Jan-07-2022)
    9,233
    Market Cap (Jan-07-2022)
    1.03 Billion USD
    Headquarters Country
    Company Profile
    Atai is a biopharmaceutical company that leverages a decentralised platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs of patients. Headquarters is in Germany.
  4. Aveanna Healthcare Holdings Inc.

    World Rank (Aug-2026)
    5,377
    Market Cap (Aug-2026)
    2.683 Billion USD
    World Rank (Jan-05-2024)
    12,643
    Market Cap (Jan-05-2024)
    0.498 Billion USD
    World Rank (Jul-30-2023)
    15,458
    Market Cap (Jul-30-2023)
    0.322 Billion USD
    World Rank (Dec-25-2022)
    19,788
    Market Cap (Dec-25-2022)
    0.143 Billion USD
    World Rank (Jan-07-2022)
    8,480
    Market Cap (Jan-07-2022)
    1.20 Billion USD
    Annual Revenue in USD
    2,433 Million USD
    Annual Operating Income in USD
    256 Million USD
    Annual Net Income in USD
    225 Million USD
    Annual Results for Period Ending
    For year ending January-2026
    Headquarters Country
    Company Profile

    Aveanna Healthcare Holdings Inc. is a national leader in healthcare as well as homecare company with growing network of more than 300 branch offices, offering a variety of care and services to more than 40,000 children and adults. The company annual revenue is 1,678 million USD for year ending January 2022. The headquarters is in USA.

  5. Trevi Therapeutics

    World Rank (Aug-2026)
    5,440
    Market Cap (Aug-2026)
    2.630 Billion USD
    World Rank (Jan-05-2024)
    22,095
    Market Cap (Jan-05-2024)
    0.088 Billion USD
    World Rank (Jul-30-2023)
    20,000
    Market Cap (Jul-30-2023)
    0.138 Billion USD
    World Rank (Dec-25-2022)
    21,267
    Market Cap (Dec-25-2022)
    0.107 Billion USD
    World Rank (Jan-07-2022)
    21,111
    Annual Operating Income in USD
    -49 Million USD
    Annual Net Income in USD
    -43 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Trevi Therapeutics is a clinical-stage biopharmaceutical company that is developing the investigational therapy Haduvio™ to treat serious chronic cough conditions by targeting the central and peripheral nervous systems. Headquarters is in USA.

  6. Axogen

    World Rank (Aug-2026)
    5,456
    Market Cap (Aug-2026)
    2.620 Billion USD
    World Rank (Jan-05-2024)
    15,954
    Market Cap (Jan-05-2024)
    0.291 Billion USD
    World Rank (Jul-30-2023)
    14,713
    Market Cap (Jul-30-2023)
    0.365 Billion USD
    World Rank (Dec-25-2022)
    13,575
    Market Cap (Dec-25-2022)
    0.420 Billion USD
    World Rank (Jan-07-2022)
    14,686
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Annual Revenue in USD
    225 Million USD
    Annual Operating Income in USD
    -8 Million USD
    Annual Net Income in USD
    -16 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Axogen is a company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. The headquarters is in USA.
    Facts About Company
    Axogen company annual revenue was 138 million USD and annual net loss was -28 million USD as on Dec-2022.
  7. Ultragenyx Pharmaceutical

    World Rank (Aug-2026)
    5,466
    Market Cap (Aug-2026)
    2.612 Billion USD
    World Rank (Jan-05-2024)
    3,549
    Market Cap (Jan-05-2024)
    3.941 Billion USD
    World Rank (Jul-30-2023)
    4,303
    Market Cap (Jul-30-2023)
    3.053 Billion USD
    World Rank (Dec-25-2022)
    4,035
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    3,267
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    673 Million USD
    Annual Operating Income in USD
    -535 Million USD
    Annual Net Income in USD
    -575 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.

  8. Kodiak Sciences

    World Rank (Aug-2026)
    5,488
    Market Cap (Aug-2026)
    2.588 Billion USD
    World Rank (Jan-05-2024)
    19,085
    Market Cap (Jan-05-2024)
    0.160 Billion USD
    World Rank (Jul-30-2023)
    19,561
    Market Cap (Jul-30-2023)
    0.150 Billion USD
    World Rank (Dec-25-2022)
    14,429
    Market Cap (Dec-25-2022)
    0.368 Billion USD
    World Rank (Jan-07-2022)
    4,108
    Market Cap (Jan-07-2022)
    3.74 Billion USD
    Annual Operating Income in USD
    -234 Million USD
    Annual Net Income in USD
    -230 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Kodiak Sciences is a Clinical Stage Biopharmaceutical company. It is specializing in novel therapeutics to treat chronic and high prevalence ophthalmic diseases. The headquarters is in USA.

  9. SELLAS Life Sciences Group

    World Rank (Aug-2026)
    5,497
    Market Cap (Aug-2026)
    2.581 Billion USD
    World Rank (Jan-05-2024)
    27,339
    Market Cap (Jan-05-2024)
    0.029 Billion USD
    World Rank (Jul-30-2023)
    25,548
    Market Cap (Jul-30-2023)
    0.047 Billion USD
    World Rank (Dec-25-2022)
    25,573
    Market Cap (Dec-25-2022)
    0.047 Billion USD
    World Rank (Jan-07-2022)
    23,258
    Market Cap (Jan-07-2022)
    0.09 Billion USD
    Annual Operating Income in USD
    -28 Million USD
    Annual Net Income in USD
    -27 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  10. Neogen Corporation

    World Rank (Aug-2026)
    5,559
    Market Cap (Aug-2026)
    2.540 Billion USD
    World Rank (Jan-05-2024)
    3,352
    Market Cap (Jan-05-2024)
    4.227 Billion USD
    World Rank (Jul-30-2023)
    2,981
    Market Cap (Jul-30-2023)
    4.993 Billion USD
    World Rank (Dec-25-2022)
    3,893
    Market Cap (Dec-25-2022)
    3.214 Billion USD
    World Rank (Jan-07-2022)
    3,668
    Market Cap (Jan-07-2022)
    4.31 Billion USD
    Annual Revenue in USD
    870 Million USD
    Annual Operating Income in USD
    -22 Million USD
    Annual Net Income in USD
    -8 Million USD
    Annual Results for Period Ending
    For year ending May-2026
    Headquarters Country
    Company Profile

    Neogen Corporation is a Food Processing, Animal Protein and Agriculture Industries company. It serve the companion and performance animal industries as well as the fields of life sciences and toxicology. The headquarters is in USA.

Share

Ads